Vnitr Lek 1996, 42(2):86-92
[Therapeutic approaches in patients after myocardial infarct].
- III. interní klinika VFN a 1. LF UK, Praha.
Klíčová slova: Adrenergic beta-Antagonists, therapeutic use, ; Angiotensin-Converting Enzyme Inhibitors, therapeutic use, ; Humans; Myocardial Infarction, drug therapy, ; Platelet Aggregation Inhibitors, therapeutic use, ; Risk Factors
Keywords: Adrenergic beta-Antagonists /therapeutic use/; Angiotensin-Converting Enzyme Inhibitors /therapeutic use/; Humans; Myocardial Infarction /drug therapy/; Platelet Aggregation Inhibitors /therapeutic use/; Risk Factors
Zveřejněno: 1. únor 1996 Zobrazit citaci